Summarized by Masters of Longevity from PR Newswire.
Jiahui launched a center to deliver CAR‑T and other cellular therapies internationally.

Key Takeaways
- The center is launched to expand CAR‑T access globally.
- Jiahui has treated international patients with CAR‑T therapies.
- Clinical evidence for long‑term outcomes remains unproven.



